주식/증권 📈 긍정적 Veracyte outlines 2027 view with ~10% volume growth and 22% adjusted EBITDA, while resetting Decipher prostate to 12,000-15,000 incremental tests Seeking Alpha - Market News 2026/11/06 04:55:31 1회 원문 기사 보기